Pharmaceuticals
Sales rise for Roche's cancer drug Add to ...
11.27 billion Swiss francs ($12.1-billion U.S.) is the third quarter sales figures from Swiss drug maker Roche. The world's biggest maker of cancer drugs is banking on a new generation of breast cancer medicines to drive sales growth. Sonia Legg reports
Watch More Video:
-
Mother chases down man trying to abduct her 4-year-old child
Crash sends car into Florida pool
Russian ship fire kills six
Daily Digit: Wal-Mart returns $3.8-billion to shareholders
-
Video: Market View: Can Google's efforts save Google+?
The Aircraft Index's economic forecast
Google tax in spotlight again
Suicide bombing targets foreign troops in Kabul
-
China and investors bet on Greece
Russia summons U.S. ambassador over spy scandal
Myanmarese refuse to evacuate for cyclone
Volcano near Mexico City threatens to erupt
-
Clashes erupt as Palestinians mark Nakba day
Demonstrators clash with police at protest in Turkey
BlackBerry parties with Alicia Keys
'Star Trek' still boldly going into the final frontier
-
Harper denies EI changes are unfair to Atlantic Canada
Jolie announces in New York Times that she had a double mastectomy
Atty Gen Orders Probe Into IRS Targeting Groups
Russia expels U.S. diplomat in spy scandal
